It might not be news that the UK research sector is strikingly international, but the scale of our global collaboration is striking – and it’s growing.
Over 60 per cent of Russell Group academics’ publications involved an international co-author in 2023, 16 per cent higher than in 2019, and in 2022 this proportion was higher for UK academics than any of our global competitors. Pooling ideas and talent makes for better research and more innovation, so supporting them to do more matters deeply to researchers – as our universities are well aware, given their own longstanding global connections.
International collaboration matters for the UK at large too, helping us tackle shared challenges and forming a large part of our global contribution. In a more uncertain world, protecting and growing research collaborations is becoming more important – complementing the government’s efforts to deepen links with the EU, protect ties with the US, and build relationships in India.
These initiatives are bound up with both security and growth. This is no accident: a strong economy is the route to creating jobs and supporting public services. We have always argued that international university partnerships should be part of the wider offer to global investors and trade partners, but we need to find new ways to demonstrate their value.
To that end, Jisc has done new analysis for the Russell Group looking at the scale and value of international research partnerships. Jisc’s unique data-matching analysis of UK, US and EU patent data held by the European Patents Office covers over 30 years of international collaboration in patent applications. The data identifies partnerships that UK institutions hold with both international companies and universities.
It’s booming
So what did we learn? Jisc’s analysis shows the proportion of patents co-filed by UK universities and an international partner grew from 12 per cent in 2000 to 22 per cent in 2022. It also found a remarkably high share of collaborations with international businesses, not just fellow academics: 43 per cent of co-filings since 2018 were with an overseas company and 36 per cent with a university abroad.
Since 2018, the data shows UK universities filed over 100 EU, US and UK patents with international partners every year. The analysis also allows us to see individual patents, not just numbers, so we can understand how impactful this work is not just to academic excellence, but to society. For example:
- the world’s first gene therapy for adults with severe haemophilia A, from pioneering research between University College London and St. Jude Children’s Research Hospital in the US
- a new type of gene therapy from Newcastle University and the University of Heidelberg in Germany, which can help to protect and strengthen muscles in people with muscular dystrophy
- improvements to machine-learning models by the University of Edinburgh and University of Manchester with Toyota in Japan – refining the ability to interpret images, a step on the way to driverless cars.
These projects, and many more of their kind, demonstrate the cutting-edge R&D that can underpin the government’s growth mission, industrial strategy and NHS ambitions. Jisc’s analysis therefore suggests that to make the most of universities’ strengths, and secure a global advantage for the UK, support for both home-grown innovation and high-value overseas collaborations will be crucial.
Potential for even more
This includes additional support for the work universities do with and for businesses, in sectors like clean energy and advanced manufacturing. Academics and innovators can do much of this themselves, but government can help by working with us to deliver a stable platform to build on including reliable funding streams, improved incentives for SME-university collaboration and a long-term strategy for industrial renewal.
We also need a strategic focus on higher education’s financial sustainability, so universities can maximise the impact of the £86bn government is committing to R&D over the next few years and support plans for economic growth and public service improvement.
It also means maintaining a supportive, stable and cost-effective visa system for staff and students – further expanding the commitments already made on building global talent pathways – so UK universities can attract and educate our future academics, innovators and collaborators, as well as securing important cross-subsidies for research and teaching. A strategic approach to skills and infrastructure across the UK would complement this, ensuring all nations and regions can benefit.
Finally, building the right platform for international collaboration means backing stable, flexible routes for academics and innovators to work together. UKRI’s work to develop lead agency agreements with counterparts in other countries has been a positive and warmly-welcomed example. Above all, however, our relationship with the world’s largest international collaborative programme for R&D – Horizon Europe, and its successor Framework Programme 10 – will be vital.
We’re currently awaiting the European Commission’s official “first draft” for FP10. We know it will be a standalone programme with a research and innovation focus, which is very reassuring. At the moment, Horizon Europe is providing more collaborative research opportunities than any one country can alone, as well as helping UK universities attract top researchers. Universities are working hard to boost Horizon participation, taking the lead in European Research Council Advanced Grant wins in 2024, and nurturing the encouraging green shoots in the collaborative Pillar II. Keeping this going is vital for global collaborations which contribute so much to our, and our partners’, economic and societal progress.
Researchers need certainty so they can rely on a shared long-term framework when building collaborations. The more open FP10 is to like-minded countries, and the more positive the UK is about association early on, the more confidence academics can be in continuing – and indeed expanding – invaluable international partnerships.